Silverback Therapeutics shares owned by DAFNA Capital Management
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by DAFNA Capital Management
from 13F filings
Historical chart of DAFNA Capital Management investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Silverback Therapeutics by DAFNA Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $1.7M | 311k | 5.48 |